For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events (MDEs) known as CRAB: Diagnosis also required -- and still does -- the ...

This year's game had an extra layer of emotion that brought the Panthers together. Assistant coach Hoa Nguyen is in a current ...

Dr. Kara Cicero is a hematologist-oncologist focused on global oncology and cancer disparities research to advance health equity, with specific clinical expertise in multiple myeloma, AL amyloidosis ...

It may also occur in association with multiple myeloma (Smith, 2003). Secondary amyloidosis occurs in association with chronic inflammatory or infectious diseases. Most patients who are diagnosed ...

Genmab presents a long-term investment opportunity, but uncertainties around Darzalex's pending patent expiration warrant a ...

In addition, the company offers DARZALEX/DARZALEX FASPRO for multiple myeloma (MM) and light-chain Amyloidosis; RYBREVANT for NSCLC; TECVAYLI and TALVEY for R/R MM; Kesimpta for Relapsing multiple ...

The global pharmaceutical industry could generate about $1.2 trillion in sales in 2025, according to Statista, and projections call for 4.7% annual growth through 2029. The cancer treatment ...

Learn more about whether Alvotech or Halozyme Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, ...

Kumar holds leadership roles in multiple research initiatives, including serving as Chair of the Myeloma, Amyloidosis, and Dysproteinemia Group. Shaji’s research focuses on hematology and oncology, ...